about
A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expressionThe lactoperoxidase system links anion transport to host defense in cystic fibrosisGammadelta T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-alpha and IFN-gamma-producers in response to Pseudomonas aeruginosaMidkine in host defenceAdeno-associated virus: from defective virus to effective vectorAirway hydration and COPDAdaptive Posttranslational Control in Cellular Stress Response Pathways and Its Relationship to Toxicity Testing and Safety AssessmentDeletion of the ubiquitin ligase Nedd4L in lung epithelia causes cystic fibrosis-like diseaseCystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation.New models of the tracheal airway define the glandular contribution to airway surface fluid and electrolyte composition.Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth.Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.Man Is not a rodent: aquaporins in the airways.Mucus clearance as a primary innate defense mechanism for mammalian airways.Insulin-like growth factor 1 (IGF-1) enhances the protein expression of CFTR.Current status of gene therapy for inherited lung diseasesRegulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages.Hyperosmolarity invokes distinct anti-inflammatory mechanisms in pulmonary epithelial cells: evidence from signaling and transcription layers.Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung.ATP release via anion channels.The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and compositionStatus of fluid and electrolyte absorption in cystic fibrosis.MAST205 competes with cystic fibrosis transmembrane conductance regulator (CFTR)-associated ligand for binding to CFTR to regulate CFTR-mediated fluid transportRepurposing tromethamine as inhaled therapy to treat CF airway disease.A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System.Recovery of ΔF508-CFTR function by analogs of hyaluronan disaccharide.Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis.Osteopontin binds and modulates functions of eosinophil-recruiting chemokines.The vacuolating toxin of Helicobacter pylori mimicks the CFTR-mediated chloride conductance.Functional and molecular characterization of an anion exchanger in airway serous epithelial cells.Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?Abnormalities in the pulmonary innate immune system in cystic fibrosisIsolation and culture of airway epithelial cells from chronically infected human lungs.Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosis.Additional disruption of the ClC-2 Cl(-) channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models.Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid.High expression of midkine in the airways of patients with cystic fibrosis.A novel neutrophil elastase inhibitor prevents elastase activation and surface cleavage of the epithelial sodium channel expressed in Xenopus laevis oocytes.
P2860
Q24291900-27A26EED-DF07-46F7-B041-2C530D170EABQ24683917-FBED109C-ED3C-47FB-953E-60F05E0A2B47Q24802511-5506A729-4ECF-4E4A-AA79-56B832281750Q27010045-07449B26-6F20-4829-B4B1-FF03C5C1DDABQ27498163-75DCF625-4F89-4CC7-A68D-C9620F11954AQ28082617-2AF3925E-04D9-4FC0-96F2-7DF86E33960BQ28383566-D743CEA9-210D-4EA5-8978-1010F15DC7BCQ28512734-1C75E499-8E9C-4476-9B81-DEDA0177CFC5Q31663553-7C724782-88AB-4ADD-BCB1-9181B40EE9A8Q31834471-1C3B96B6-6770-40F2-879A-B4344DD9938AQ33929671-9AF113B1-07AB-4D03-9CF4-4D63754FCB36Q33950252-0C0DA06E-BF6F-4398-9DC3-141367834E59Q34008714-F856DF99-14E0-4F42-98FF-D84E5CB05E5BQ34179092-1D20EE65-5BC0-4DFC-9371-41F53739E4D4Q34551378-4B759528-6131-43D2-9AD7-FB79F33A1E39Q34652853-845513D2-64D9-446A-A361-DA987FBD8606Q35043830-CB96300E-D459-4034-9503-BACAA2E40B1BQ35221848-78B3A7C6-81BC-4E76-971C-764683DADBD0Q35494634-9176D9EB-61B6-4D1E-A73E-2119AFDB30DBQ35864774-7BBD4ACF-EAF8-4DA6-88DD-C765DE19028BQ36079160-96D93E98-C92D-458C-8523-4FE73A7F0853Q36173784-5F216688-F32C-491F-99AD-614DDE2C400FQ36445182-921ADE31-7D38-478D-BBE3-C6C7865169D5Q36488263-0FE32316-4CA3-4D26-91A7-028478286CF7Q36796953-B080AA36-ECE1-47C0-BD4A-96E3E3D71790Q37066264-1A16EB3E-30F5-4520-BF84-8A7D25EF8F3EQ38670784-1E901519-BB09-4B5C-8580-33170B0710D5Q39481242-C266524B-FC2D-4807-856F-C19825FDCAF8Q40014245-AC042072-1330-42A8-965F-3586F8391D3DQ40495329-CE319F75-9604-4868-8A97-B56E7DCE62D2Q40686303-3EFE5E0B-830F-4261-9554-DFCC608C8601Q40852829-61532FC6-0BDC-43EB-B5E9-F06B5C589F93Q41992050-D19A0E7E-D5FC-47E6-874D-8B9657A5EA03Q42066758-0B89CB19-3D27-488D-A223-D7755A112A13Q43773707-11C0E9A8-8105-4646-87FE-EC8E9FAD8581Q44024796-8AB7365A-7C90-4C54-A04F-F135918216C4Q44790624-1A673F4D-87B6-4109-9327-BBB6638EE23BQ45878847-E618612C-1548-4E82-B816-06E4EED31296Q46308388-52DD2478-EB8E-4895-B25D-FA26BC446818Q50642950-5545683E-7FB5-4002-B206-B13A2733FCE7
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cystic fibrosis and the salt controversy.
@ast
Cystic fibrosis and the salt controversy.
@en
Cystic fibrosis and the salt controversy.
@nl
type
label
Cystic fibrosis and the salt controversy.
@ast
Cystic fibrosis and the salt controversy.
@en
Cystic fibrosis and the salt controversy.
@nl
prefLabel
Cystic fibrosis and the salt controversy.
@ast
Cystic fibrosis and the salt controversy.
@en
Cystic fibrosis and the salt controversy.
@nl
P1433
P1476
Cystic fibrosis and the salt controversy.
@en
P2093
Guggino WB
P304
P356
10.1016/S0092-8674(00)80570-X
P407
P577
1999-03-01T00:00:00Z